Results 131 to 140 of about 1,619,601 (310)
Substrate-competitive activity-based profiling of ester prodrug activating enzymes
Brent R. Martin
openalex +2 more sources
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang +3 more
wiley +1 more source
An enzyme activation network reveals extensive regulatory crosstalk between metabolic pathways. [PDF]
Al Zubaidi SM +4 more
europepmc +1 more source
Structure, function and inhibition of poly(ADP-ribose)polymerase, member 14 (PARP14) [PDF]
Levonis, Stephan M +3 more
core +1 more source
Inhibitor-induced enzyme activation in organic solvents.
Alan J. Russell, Alexander M. Klibanov
openalex +1 more source
FCS of Mutated Phosphatidylinositol-specific Phospholipase C Enzymes Monitors the Interplay of Substrate and Activator Lipid Binding [PDF]
Mingming Pu +2 more
openalex +1 more source
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee +8 more
wiley +1 more source
Frequency-Dependent Premature Differentiation of Pheochromocytoma Cells Exhibits Band-Pass Filter Behavior Correlation with Intracellular Enzyme Activation Kinetics. [PDF]
Ningsih Z, Tran NHN, Clayton AHA.
europepmc +1 more source

